[Effect of Qingxue Dan on obesity and metabolic biomarker: a double-blind randomized-controlled pilot study].

CONCLUSION: 8-weeks of oral administrations of QXD (900 mg/d) reduces BMI, with a tendency of lose of total body fat mass, especially abdominal fat. It also significantly reduced serum TG level. These results suggest QXD could be used to treat obesity and metabolic risk factors. Further study is needed to confirm our pilot findings. PMID: 27468542 [PubMed - in process]
Source: Journal of Traditional Chinese Medicine - Category: Complementary Medicine Authors: Tags: J Tradit Chin Med Source Type: research